scorecardresearch
Add as a preferred source on Google
Saturday, November 1, 2025
TopicHypertension

Topic: hypertension

Experimental drug shows promise in treatment of hard-to-control high blood pressure

AstraZeneca’s experimental drug baxdrostat cut systolic BP by nearly 10 mmHg in a late-stage trial, offering hope to patients at a high risk of heart attacks, among others.

Researchers bat for price cap for hypertension fixed-dose combinations as trial proves efficacy

If included in National List of Essential Medicines (NLEM), the fixed-dose combinations (FDCs) to rein in hypertension can be made available free of cost to patients through government hospitals.

ICMR-NIE launches initiative to tackle poor follow-ups, gaps in diabetes, hypertension treatment

Fewer than 10 percent of people with hypertension had their blood sugar under control & fewer than 66 percent of diabetics had metabolic disorder under control in 2019-21.

Take that salt shaker off the table, say doctors at talk on India’s non-communicable diseases burden

Non-communicable diseases account for over 60% deaths in India, with cardiovascular diseases being the leading cause. The trend is attributed to excessive salt consumption.

Over 40% hospitals below district level lack basic diabetes, hypertension drugs—ICMR-WHO survey of 7 states

Survey also found a shortage of 82.2% physicians and 83.2% surgeons at community health centre-level facilities, considered crucial for providing secondary-level healthcare services. 

Swap table salt with low sodium substitutes, says WHO. Why Indian doctors say this can save lives

According to medical experts, the new guidance is a transformative step toward reducing hypertension & cardiovascular disease globally, including India.

Almost 50% Indian men, 37% women with hypertension don’t have BP in control—analysis of NFHS data

Analysis by researchers associated with institutions including Mumbai's Indian Institute of Population Sciences & Post Graduate Institute of Medical Education and Research, Chandigarh.

Trial in India finds 2-drug combinations 5 times more effective than single pill in controlling hypertension

Amlodipine & perindopril, amlodipine & indapamide, and perindopril & indapamide achieved blood pressure control in 70 percent of patients to less than 140/90 mm Hg in six months.

Yoga, dual therapies — 1st India-specific guidelines for those with both hypertension & diabetes

Key feature of guidelines is emphasis on using multiple methods to measure hypertension, including home BP monitoring. For the first time, yoga is recommended as an adjunct therapy

Hypertension care guidelines miss out on endorsing low-sodium & potassium-enriched salt, says study

In global collaboration, researchers reviewed 32 guidelines, including India’s & published results in journal 'Hypertension', found only China & Europe recommend potassium-enriched salt.

On Camera

Rahul and Modi turn Bihar into a national showdown. Tejashwi keeps it local

Rahul’s prolonged absence from Bihar, along with the bloc’s delayed decision to name Tejashwi as CM candidate, finally gave the RJD leader the space to step onto the electoral turf with confidence.

Consumer Price Index gets up to date. Airfare, OTT plans, e-commerce prices in new basket—MoSPI secy

New CPI series will take 2024 as base year, will provide more accurate measure of inflation, spending on digital services. Expected to enhance representation and reliability, says Saurabh Garg.

Joint production, closer ties, emerging tech: The foundation of new defence pact between India & US

The agreement, signed after meeting between Rajnath and US Secretary of War Pete Hegseth on sidelines of ADMM-Plus in Kuala Lumpur, aims to deepen bilateral ties in the critical sector.

Trump’s trade wars have rewritten powerplay, but India didn’t get the memo

This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.